글로벌 계약 제약 포장 시장 – 2030년까지의 산업 동향 및 예측

계약 제약 포장 시장 분석 및 규모

계약 제약 포장 시장은 제약 회사의 포장 서비스로 구성된 제약 산업 내의 중요한 부문입니다. 이 시장은 효율적인 포장 솔루션에 대한 수요 증가와 엄격한 규정에 의해 주도되고 있으며, 환자 안전과 혁신 기술에 대한 강조가 커지면서 계약 제약 포장 부문은 꾸준한 성장을 향해 나아가고 있습니다.

Data Bridge Market Research에 따르면 글로벌 계약 제약품 포장 시장은 2030년까지 10,313,375.65달러 규모에 도달할 것으로 예상되며, 이는 예측 기간 동안 7.4%의 CAGR로 성장할 것으로 예상됩니다.

시장 정의

The contract pharmaceutical packaging market encompasses a specialized sector within the pharmaceutical industry, focusing on tailored packaging solutions. It involves the design, development, and production of primary, secondary, and tertiary packaging, and labeling and artwork management solutions for pharmaceutical products. Key market drivers include increased demand, the need for complex packaging due to innovative products, and stringent regulations. Notable trends include the adoption of postponement packaging for efficiency and reduced wastage, serialization for data integrity and supply chain improvements, and a shift toward eco-friendly materials to minimize environmental impact. This market aims to preserve product integrity, user-friendliness, and marketability while complying with industry regulations and guidelines.

Global Contract Pharmaceutical Packaging Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers:

• High Spending Towards Pharma Industry

In recent years, pharmaceutical companies have been increasingly developing complex drug formulations to enhance drug efficacy, improve patient compliance, and reduce side effects. These formulations often require precise dosing, specialized delivery mechanisms, and controlled release profiles. Therefore, pharmaceutical packaging has evolved beyond simple blister packs and bottles. The demand for specialized packaging that can preserve the integrity of these complex formulations while ensuring accurate dosing and administration has surged. This shift has opened up opportunities for contract packaging providers who possess the technical expertise to handle these intricate packaging requirements.

• Impact of Complex Drug Formulations and Specialized Packaging Needs

The substantial rise in financial allocation within the pharmaceutical industry has emerged as a significant catalyst for the expansion of the global contract pharmaceutical packaging market. This upsurge in investment can be attributed to several factors collectively driving the growth of the packaging sector. The escalating demand for pharmaceutical products, driven by factors such as aging populations and the prevalence of chronic diseases, has led to heightened production volumes. This surge in production naturally entails a proportional need for packaging services. Contract pharmaceutical packaging providers step in to fulfil this demand by offering scalable solutions that cater to diverse product portfolios and quantities.

Opportunities

• Technological Advancements in Packaging Machinery and Materials

Technological advancements in packaging machinery and materials have been instrumental in shaping the landscape of the global contract pharmaceutical packaging market. These advancements, driven by innovations in automation, materials science, and sustainability, are poised to create substantial opportunities for market growth. One key aspect of technological advancement is the automation of packaging processes. Modern packaging machinery is equipped with sophisticated robotic systems, computerized controls, and real-time monitoring capabilities. This translates to enhanced precision, efficiency, and reduced human errors in the packaging process.

• Rising Need for Biopharmaceutical Cold Chain Packaging

The escalating demand for biopharmaceutical cold chain packaging has emerged as a pivotal driver in the pharmaceutical industry, fostering substantial opportunities for the growth of the global contract pharmaceutical packaging market. This surge is underpinned by the imperative need to maintain the efficacy and integrity of temperature-sensitive biopharmaceutical products throughout their intricate supply chains. Biopharmaceuticals, including vaccines, gene therapies, and specialized drugs, are often vulnerable to temperature variations, necessitating stringent temperature control during storage and transportation.

Restraints/ Challenges

• Availability of Choice of In-House Packaging from Manufacturers

In the realm of contract packaging, the availability of in-house packaging choices from manufacturers has emerged as a significant factor. Companies are constantly seeking avenues to enhance efficiency and optimize their production and packaging processes. The trend towards investing in automating packaging processes in-house has gained substantial traction. The prospect of packaging products in-house presents a profitable opportunity for businesses that are looking into new market territories or those seeking to streamline their established operations. This involves acquiring capital packaging equipment and conducting the packaging process within the company's facilities. This states that in-house packaging can yield good returns over a long period, with ongoing expenses limited to personnel wages, maintenance, and replacement of worn parts.

• Sustainability Concerns due to Usage of Plastics in Packaging Materials

The extensive use of single-use plastics in pharmaceutical packaging, while serving the purpose of maintaining product integrity and patient safety, contradicts the growing sustainability concerns worldwide. The pharmaceutical sector's adherence to good manufacturing practices (GMP) is essential for ensuring the quality and safety of drugs, but these regulations often lack explicit guidance on sustainable packaging practices. This leads to practices such as double packaging with plastic liners and ties, and the internal lining of equipment with plastic to avoid cleaning costs. These practices align with GMP but run counter to sustainable objectives, resulting in environmental challenges. GMP ensures patient safety and product quality, it doesn't prioritize environmental sustainability. This contradiction showcases the industry's struggle to balance patient well-being with environmental responsibility.

• Diverse Concerns Related to Operational Hurdles

The contract pharmaceutical packaging has its advantages however encounters a wide range of challenges that are risen from diverse concerns related to operational hurdles. In a landscape where packaging dynamics are constantly changing the complexities of the packaging supply chain have become a problem of concern. The essential role of packaging engineers in designing folding cartons and ensuring consistent label line operations is vital. However, the pursuit of competitive pricing often clashes with the need to meet production teams' demands for timely and complete orders.

One challenge is the lack of available space for production in densely populated areas and high-value real estate locations. The imperative to maximize profitability within confined spaces places immense pressure on contract packaging equipment to enhance productivity. Changeovers, another challenging aspect, pose a direct threat to efficiency and profitability.

Recent Developments

• In December 2022, Nelipak Corporation established a cutting-edge flexible packaging production site in Winston-Salem, North Carolina. This strategic move will extend Nelipak's healthcare packaging capabilities from Europe to the Americas, catering to the increasing demand in the region. The 110,000 square-foot facility, equipped with ISO-7 clean room space and ISO 13485 certification, represents a USD 20 million investment and is projected to generate approximately 80 jobs over the next five years.
• In October 2022, Aphena Pharma Solutions Inc. announced that its USD 20 million expansion and renovation, which began mid-2019 in Cookeville, Tennessee, is now complete, adding a large amount of available solid dose packaging capacity. This added space has allowed Aphena to grow the company’s bottle and blister packaging capacity largely, with four additional high-speed bottling lines and two additional high-speed blister lines for solid-based products, making Aphena a strong strategic growth partner for any generic or OTC pharmaceutical company.
• In September 2022, Nelipak Corporation achieved International Sustainability and Carbon Certification (ISCC) PLUS for its facilities in Phoenix, AZ, and Whitehall, PA. This recognition highlighted Nelipak's dedication to sustainable practices, utilizing a circular supply chain by incorporating recycled and bio-based materials.
• In October 2020, Alnylam Pharmaceuticals partnered with Sharp to package its approved RNAi therapeutic products in European markets. Sharp's Hamont-Achel site in Belgium will handle the packaging for Alnylam's offerings across European countries. This collaboration marked a significant international investment for Alnylam in Belgium, aligning with their strategy to enhance their presence in the region and establish it as a key hub for operations.
• In May 2020, Sharp, acquired a pharmaceutical packaging facility in Macungie, Pennsylvania. This facility, formerly owned by Quality Packaging Specialists International, LLC (QPSI), spans 160,000 sq. ft. and is fully equipped for primary and secondary pharmaceutical packaging, including bottling, blistering, vial labeling, medical device kitting, and serialization services. The strategic acquisition catered to escalating client volume demands, bolstering Sharp's capacity to provide efficient packaging solutions.

Global Contract Pharmaceutical Packaging Market Scope

The global contract pharmaceutical packaging market is segmented into type, raw material, and application. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Primary Packaging System
• Secondary Packaging System
• Tertiary Packaging System

On the basis of type, the market is segmented into primary packaging system, secondary packaging system, and tertiary packaging system.

Raw Material

• Plastic & Polymers
• Glass
• Metals
• Paper & Board
• Rubber
• Cotton
• Others

On the basis of raw material, the market is segmented into plastic & polymers, glass, metals, paper & board, rubber, cotton, and others.

Application

• Transmucosal Drug Delivery Packaging
• Pulmonary Drug Delivery Packaging
• Nasal Drug Delivery Packaging
• Topical Drug Delivery Packaging
• Injectable Packaging
• Oral Drug Delivery Packaging
• Others

On the basis of application, the market is segmented into transmucosal drug delivery packaging, pulmonary drug delivery packaging, nasal drug delivery packaging, topical drug delivery packaging, injectable packaging, oral drug delivery packaging, and others.

Global Contract Pharmaceutical Packaging Market Regional Analysis/Insights

The global contract pharmaceutical packaging market is analyzed and market size insights and trends are provided by country on type, raw material, and application as referenced above.

글로벌 계약 제약품 포장 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코, 독일, 영국, 프랑스, ​​이탈리아, 스페인, 네덜란드, 벨기에, 러시아, 터키, 스위스, 룩셈부르크, 유럽의 나머지 지역, 중국, 인도, 일본, 한국, 호주, 뉴질랜드, 인도네시아, 싱가포르, 말레이시아, 태국, 필리핀, 아시아 태평양의 나머지 지역, 브라질, 아르헨티나, 남미의 나머지 지역, 아랍에미리트, 남아프리카, 이집트, 사우디 아라비아, 이스라엘, 중동 및 아프리카의 나머지 지역입니다.

북미 지역은 효율적인 포장 솔루션에 대한 수요 증가와 엄격한 규제로 인해 시장을 주도하고 성장할 것으로 예상됩니다. 미국은 빠르게 변화하는 소비자 선호도와 증가하는 환경 문제를 충족하기 위한 혁신적인 포장 방법의 채택이 확대됨에 따라 북미 지역에서 우위를 점할 것으로 예상됩니다. 독일은 소비와 수요가 증가함에 따라 유럽 지역에서 우위를 점할 것으로 예상됩니다. 중국은 전 세계 다양한 제약 산업에서 상당한 개발과 투자가 이루어짐에 따라 아시아 태평양 지역에서 우위를 점할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 추세 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 글로벌 계약 제약 포장 시장 점유율 분석

글로벌 계약 제약 포장 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 회사의 시장 집중과만 관련이 있습니다.

글로벌 계약 제약품 포장 시장의 주요 기업으로는 AbbVie Inc, PCI Pharma Services Nelipak Healthcare, Sharp Services, LLC, Aphena Pharma Solutions, ROPACK INC., SilganUnicep 2, Reed-Lane, Jones Healthcare Group, Wasdell Packaging Group, SternMaid & Co. KG, Sepha, Tripak Pharmaceuticals, Assemblies Unlimited, Inc., AmeriPac, Tjoapack 등이 있습니다.

SKU-54534